Working great Im down to 192 pounds
Methylcobalamin and Other Forms Methylcobalamin is an active Vitamin B12 form used in some injections
See Product Specifications for more detailed Information Skip to the beginning of the images gallery Details Manufacturer # 00517013005 Manufacturer American Regent Application Vitamin B-12 Container Type Multiple Dose Vial Dosage Form Injection Generic Drug Code 94594 Generic Drug Name Cyanocobalamin NDC Number 00517-0130-05 Strength 1,000 mcg / mL Type Intramuscular or Subcutaneous UNSPSC Code 50501509 Volume 30 mL More Information More Information SKU 922754-00517013005 Color No Brand American Regent Manufacturer Part Number 00517013005 Size X-Large Reviews Write Your Own Review You're reviewing: Vitamin B-12 Cyanocobalamin 1,000 mcg / mL Intramuscular or Subcutaneous Injection Multiple Dose Vial 30 mL (BX/5) Nickname Summary Review Submit Review More from this Brand (4) Products from the same brand Rating: 0% AB-Rated Generic Equivalent to Celestone Soluspan Betamethasone Sodium Phosphate / Betamethasone Acetate 6 mg / mL Injection Multiple Dose Vial 5 mL American Regent 00517072001 725645-00517072001 $113.72 Add to Wish List Add to Cart Add to Compare Rating: 0% Atropine Sulfate, Preservative Free 1 mg / mL Intramuscular, Intravenous or Subcutaneous Injection Single Dose Vial 1 mL American Regent 00517101025 954298-00517101025 As low as $26.06 Add to Wish List Add to Cart Add to Compare Rating: 0% Methylene Blue 50 mg / mL Injection Ampule 10 mL American Regent 00517037405 1028218-00517037405 $2,447.30 Add to Wish List Add to Cart Add to Compare Rating: 0% CYANOCOBALAMIN, MDV 1000MCQ/ML30ML (1/EA) American Regent 00517013001 226417-00517013001 $253.48 Add to Wish List Add to Cart Add to Compare
Standard Dosing Ranges The most extensively studied dosing protocols for subcutaneous administration include: Research-Based Dosing Protocols Beginner/Conservative Protocol: Dose: 250-300 mcg once daily Duration: 4-8 weeks initial assessment period Rationale: Allows tolerance assessment and response evaluation at lower end of therapeutic range Standard Protocol: Dose: 300-500 mcg once daily Duration: 12-24 weeks based on clinical trials Rationale: Most commonly studied range in human research with optimal benefit-to-safety ratio Advanced Protocol: Dose: 500 mcg-1 mg once daily Duration: 12-24 weeks under close medical monitoring Rationale: Upper clinical range
Nausea, vomiting, diarrhea, upset stomach, constipation, and bloating can all occur
